Perhaps the accumulation of knowledge about the differences between β-cells in the context of their sensitivity to stress is a direct way to develop a strategy for diabetes therapy based on the maintenance or expansion of the population of immature β-cells and their further maturation for the regeneration of the population of insulin-secreting cells. The gene discussed is INS; the disease is diabetes mellitus.